Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells-Reference-Cited by-同舟云学术

Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells

Published:2020-10 Issue: Volume:203 Page:112540
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wu Wei-Cheng,Liu Yi-Min,Liao Yu-Hsuan,Hsu Kai-Cheng,Lien Ssu-Ting,Chen I-Chung,Lai Mei-Jung,Li Yu-Hsuan,Pan Shiow-Lin,Chen Mei-Chuan,Liou Jing-Ping^ORCID

Funder

Ministry of Science and Technology (MOST), Taiwan

“TMU Research Center of Cancer Translational Medicine”

Ministry of Education (MOE) in Taiwan

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference49 articles.

1. Effects of treatment with an Hsp90 inhibitor in tumors based on 15 phase II clinical trials;Wang;Mol Clin Oncol,2016

2. Heat shock proteins in toxicology: how close and how far?;Gupta;Life Sci.,2010

3. Heat shock proteins: a review of the molecular chaperones for plant immunity;Park;Plant Pathol. J.,2015

4. The HSP90 family: structure, regulation, function, and implications in health and disease;Hoter;Int. J. Mol. Sci.,2018

5. Hsp90 and Hsp70 chaperones: collaborators in protein remodeling;Genest;J. Biol. Chem.,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids;European Journal of Medicinal Chemistry;2024-11

2. Small molecule inhibitors targeting heat shock protein 90: An updated review;European Journal of Medicinal Chemistry;2024-09

3. HSP90: A promising target for NSCLC treatments;European Journal of Pharmacology;2024-03

4. Design and synthesis of alepterolic acid and 5-fluorouracil conjugates as potential anticancer agents;Mendeleev Communications;2022-05

5. Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922;Frontiers in Oncology;2022-02-24